Düsseldorf and New York – April 3, 2024 – AW Technologies and Asahi Kasei Medical, a core operating company of the Japanese technology company Asahi Kasei, have entered into an exclusive distribution agreement in Japan for AW Technologies“ TrachFlush™ device. AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.
Developed by AW Technologies based on an invention by an intensivist, the TrachFlush is a medical device to reduce the discomfort of ventilated patients while lightening the workload on healthcare professionals during tracheal suctioning. The TrachFlush supports airway secretion (phlegm) management with a unique cuff pressure control system. With the push of a button, the TrachFlush deflates the cuff and utilizes the ventilator air pressure during an inspiratory cycle, and re-inflates the cuff before the cycle completes. TrachFlush has received the CE Mark in Europe in 2020 and FDA clearance in the United States in 2023. In Japan, marketing and sale is to be performed by Asahi Kasei Medical.
Ken Shinomiya, President of Asahi Kasei Medical, stated, „We are delighted to add the TrachFlush to our product lineup in the intensive care field, where we have strength in the area of blood purification. By leveraging our experience and know-how in blood purification, we believe that this will deliver diverse value, such as enhancing patients“ QOL and reducing the burden on healthcare workers.“ Adam Hansen, CEO of AW Technologies, commented, „We are very pleased and excited to announce our partnership with Asahi Kasei Medical. This partnership is very important for AW Technologies, and Asahi Kasei Medical will play a very important role in our expansion of TrachFlush globally. We believe the TrachFlush will have a great impact in the ICU – not only by preventing ventilator-associated pneumonia, but also by non-invasively preventing the accumulation of secretion in the airways.“
About AW Technologies ApS
AW Technologies is a Danish medical device company, established in 2018, focused on developing disruptive and innovative airway management solutions for mechanically ventilated patients in the ICU, including TrachFlush. For further information, please visit www.trachflush.com and www.awtechnologies.dk
About Asahi Kasei Medical
Asahi Kasei Medical is a core operating company in the Health Care sector. Its blood purification business comprises devices and systems for dialysis and therapeutic apheresis, and its bioprocess business comprises equipment for the manufacture of biotherapeutics, biosafety testing services, and biologics CDMO operations. For more information, visit www.asahi-kasei.co.jp/medical/en/
About Asahi Kasei
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 48,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care. Its Material sector, comprised of Environmental Solutions, Mobility & Industrial, and Life Innovation, includes a wide array of products from battery separators and biodegradable textiles to engineering plastics and sound solutions. For more information, visit www.asahi-kasei.com
Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/
Europe Contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
sebastian.schmidt@asahi-kasei.eu
North America Contact
Asahi Kasei America Inc.
Christian OKeefe
christian.okeefe@ak-america.com
About the Asahi Kasei Corporation
Asahi Kasei Corporation is a globally active diversified technology company with operations in the Material, Homes, and Health Care business sectors. The Material sector encompasses fibers & textiles, petrochemicals, performance polymers, performance materials, consumables, battery separators, and electronic devices. The Homes sector provides housing and construction materials to the Japanese market. The Health Care sector includes pharmaceuticals, medical devices, and acute critical care devices and systems. With more than 46,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries and achieved sales of 20 billion euros (2.726 billion yen) in the fiscal year 2022 (April 1, 2022 – March 31, 2023).
Asahi Kasei is „Creating for Tomorrow“ with all operations sharing a common mission of contributing to life and living for people around the world. For more information, visit
www.asahi-kasei.eu, www.asahi-kasei.com and https://www.asahi-kasei.com/sustainability/
Company-Contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstraße 17
40221 Düsseldorf
Phone: +49 (0)211 3399-2058
E-Mail: 
Url: https://www.asahi-kasei.eu/
Press
financial relations GmbH
Henning Küll
Louisenstraße 97
61348 Bad Homburg
Phone: +49 (0) 6172 27159 12
E-Mail: 
Url: http://www.financial-relations.de
Bildquelle: Asahi Kasei
